Cinnamic aldehydes affect hydrolytic enzyme secretion and morphogenesis in oral Candida isolates

Microbial Pathogenesis

Volumn 52, Issue 5, 2012, Pages 251-258

  Shreaz, Sheikh ^a   Bhatia, Rimple ^a   Khan, Neelofar ^a   Maurya, Indresh Kumar ^b   Ahmad, Sheikh Imran ^a   Muralidhar, Sumathi ^c   Manzoor, Nikhat ^a   Khan, Luqman A ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

Candida albicans; Cinnamaldehyde; Phospholipase; Proteinase; Yeast hyphal transition

Indexed keywords

3,5 DIMETHOXY 4 HYDROXY CINNAMALDEHYDE; 4 HYDROXY 3 METHOXY CINNAMALDEHYDE; CINNAMALDEHYDE; CINNAMALDEHYDE DERIVATIVE; FLUCONAZOLE; PHOSPHOLIPASE; PROTEINASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME RELEASE; FUNGUS GROWTH; FUNGUS HYPHAE; FUNGUS ISOLATION; FUNGUS MORPHOGENESIS; HEMOLYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ACROLEIN; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; FUNGAL PROTEINS; HUMANS; HYPHAE; MICROBIAL SENSITIVITY TESTS; PEPTIDE HYDROLASES; PHOSPHOLIPASES; PROTEIN TRANSPORT;

CANDIDA; CANDIDA ALBICANS;

EID: 84858862604     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.11.005     Document Type: Article

References (32)

1. Pfaller M.A., Diekema D.J., Jones R.N., Messer S.A., Hollis R.J. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002, 40:852-856.
2. Calderone R.A., Fonzi W.A. Virulence factors of Candida albicans. Trends Microbiol 2001, 9:327-350.
3. Webb B.C., Thomas C.J., Willcox M.D., Harty D.W., Knox K.W. Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by candida species. Aust Dent J 1998, 43:160-166.
4. Banerjee U. Progress in diagonosis of opportunistic infection in HIV/AIDS. Indian J Med Res 2005, 121:395-406.
5. Sanglard D., Ischer F., Parkinson T., Falconer D., Bille J. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 2003, 47:2404-2412.
6. Ghannoum M. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000, 13:122-143.
7. Neugnot V., Moulin G., Dubreucq E., Bigey F. The lipase/acyltransferase from Candida parapsilosis: molecular cloning and characterization of purified recombinant enzymes. Eur J Biochem 2002, 269:1734-1745.
8. Ibrahim A.S., Mirbod F., Filler S.G. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995, 63:1993-1998.
9. Cassone A., De Bernardis F., Mondello F., Ceddia T., Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis, 1987 proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987, 156:777-783.
10. Jones S., White G., Hunter P.R. Increased phenotypic switching in strains of Candida albicans associated with invasive infections, 1994 associated with invasive infections. J Clin Microbiol 1994, 32:2869-2870.
11. Farrels M., Hawkinsd F., Rydert A. Scanning electron microscope study of Candida albicans invasion of cultured human cervical epithelial cells. Sabouraudia 1983, 21(25):1-254.
12. Sobel J.D., Obedeanun Effects of sub inhibitory concentrations of ketoconazole on in vitro adherence of Candida albicans to vaginal epithelial cells. Eur J Clin Microbiol 1983, 2:445-452.
13. Smith C.B. Candidiasis: pathogenesis, host resistance and predisposing factors. Candidiasis 1985, 53-70.
14. Julnar U., Sawsan K., Pascale B., Yolla B.M., Hania N.C. Comparative study on the effect of Cinnamaon and clove extracts and their main components on different types of ATPases. Hum Exp Toxicol 2003, 22:335-362.
15. Bang K.H., Lee D.W., Park H.M., Rhee Y.H. Inhibition of fungal cell wall synthesizing enzymes by trans-cinnamaldehyde. Biosci Biotechnol Biochem 2000, 64:1061-1063.
16. Xie X.M., Fang J.R., Xu Y. Study of antifungal effect of cinnamaldehyde and citral on Aspergillus flavus. Food Sci 2004, 09.
17. Set-Young D., Monk B.C., Mason A.B., Perlin D.S. Exploring an antifungal target in the plasma membrane H+ ATPase of fungi. Biochim Biophys Acta 1997, 1326:249-256.
18. Taguchi Y., Takizawa T., Ishibashi H., Sagawa T., Arai R., Inoue S., et al. Therapeutic effects on murine oral candidiasis by oral administration of cassia (Cinnamomum cassia) preparation. Nihon Ishinkin Gakkai Zasshi 2010, 51(1):13-21.
19. Shreaz S., Rayees A.S., Rimple B., Athar A.H., Nikhat M., Luqman A.K. Anti-candidal activity of cinnamaldehyde, its ligand and Ni (II) complex: effect of increase in ring and side chain. Microb Pathog 2010, 49:75-82.
20. Jong H.K., Kathleen L.C., Noreen M., Bruce C.C. Antifungal activity of redox-active benzaldehydes that target cellular antioxidation. Ann Clin Microbiol Antimicrob 2011, 10:23.
21. Gill A.O., Holley R.A. Mechanisms of bactericidal action of cinnamaldehyde against Listeria monocytogenes and of eugenol against L. monocytogenes and Lactobacillus sakei. Appl Biochem Biotechnol 2004, 70:5750-5755.
22. De Bernardis F., Sullivan P.A., Cassone A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol 2001, 39:303-313.
23. Shreaz S., Bhatia R., Khan N., Muralidhar S., Basir S.F., Manzoor N., et al. Spice oil cinnamaldehyde exhibits potent anticandidal activity against fluconazole resistant clinical isolates. Fitoterpia 2011, 82:1012-1020.
24. Wu T., Wright K., Hurst S.F., Morrison C.J. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole. Antimicrob Agents Chemother 2000, 44:1200-1208.
25. Kaur S., Mishra P. Dimorphism-associated changes in plasma membrane H +-ATPase activity of Candida albicans. Arch Microbiol 1991, 156:412-415.
26. NCCLS. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A2. Wayne, PA: 2002; 30.
27. Sheikh S., Rimple B., Neelofar K., Sheikh I.A., Sumathi M., Seemi F.B., et al. Interesting anticandidal effects of anisic aldehydes on growth and proton-pumping-ATPase-targeted activity. Microb Pathog 2011, 51:277-284.
28. Mardegan de C.R., Klein M.I., Golvea M.B., Rodrigues J.A.O., Goncalves R.B., Hofling J.F. Biotyping and genotypic diversity among oral Candida albicans strains from caries free and caries active healthy children. Braz J Microbiol 2006, 37:26-32.
29. Neelofar K., Shreaz S., Rimple B., Sumathi M., Nikhat M., Luqman A.K. Curcumin as a promising anti- candidal of clinical interest. Can J Microbiol 2011, 57:204-210.
30. Yousuf S., Ahmad A., Khan A., Manzoor N., Khan L.A. Effect of garlic-derived allyl sulphides on morphogenesis and hydrolytic enzyme secretion in Candida albicans. Med Mycol 2011, 49:444-448.
31. Kaur S., Mishra P. Differential increase in cytoplasmic pH at bud and germ tube formation in Candida albicans: studies of a non-germinative variant. Can J Microbiol 1994, 40:720-723.
32. Ahmed A., Khan A., Akhtar F., Yousuf S., Xess I., Khan L.A., et al. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 2011, 30:41-50.